Registered Nurse in Edwards, CO Accepting Medicare
3 Registered Nurse nurses found. Showing 1 - 3
 Karla Christensen, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 56 Edwards Village Blvd Unit 206, Edwards, CO 81632 Phone: 970-207-7171 |
 Dr. Joel T Dekanich, DC, EMT Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 105 Edwards Village Blvd, Suite A-203, Edwards, CO 81632 Phone: 970-926-4600 Fax: 970-926-4602 |
Catherine P Mast, RN NP Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 322 Beard Creek Rd, Edwards, CO 81632 Phone: 970-569-7600 Fax: 970-569-7604 |
News Archive
Research explores whether too many patents stifle progress in biomedicine
New research published by University of Utah S.J. Quinney College of Law Professor Jorge Contreras in Science this week explores the current state of sharing resources in the biomedical research field and whether the fragmentation of property ownership can stifle research progress, instead of advancing it.
Comfortable living conditions, independence can help elderly Chinese immigrants feel at home in the U.S.
Having comfortable living conditions and independence from their adult children can help elderly Chinese immigrants find a sense of home and life satisfaction in the United States, but the inability to speak fluent English makes them feel unsettled, according to a research study.
FDA calls for cuts in Acetaminophen in painkillers
The US FDA has asked for a limit on the amount of acetaminophen in prescription pain medicines in an effort to reduce the risk of liver damage. The announcement yesterday asked manufacturers to limit combination drugs such as the opioids Percocet and Vicodin to 325 milligrams of acetaminophen per pill and asked them to carry a "black box" warning about potential liver failure. At present these combinations carry up to 750 milligrams of acetaminophen.
Regeneron submits VEGF Trap-Eye BLA to FDA for treatment of wet AMD
Regeneron Pharmaceuticals, Inc. announced that the company submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for VEGF Trap-Eye for the treatment of the neovascular form of age-related macular degeneration (wet AMD). Under the Prescription Drug User Fee Act (PDUFA), the goal for a standard review time from submission to FDA action is ten months.
› Verified 8 days ago
Nurse Practitioner
Physician Assistant
Nurse Anesthetist - CR
Registered Nurse